Free Trial

Quoin Pharmaceuticals (QNRX) Insider Trading & Ownership

Quoin Pharmaceuticals logo
$7.49 -0.01 (-0.13%)
As of 01:03 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Quoin Pharmaceuticals (NASDAQ:QNRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.46%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$382.26K
Number Of
Insiders Selling
(Last 12 Months)
0
Get QNRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Quoin Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

QNRX Insider Buying and Selling by Quarter

Quoin Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/23/2024Anthony James CulverwellDirectorBuy2,857$15.75$44,997.75  
12/23/2024Denise P CarterCOOBuy15,873$15.75$249,999.75  
12/23/2024Gordon DunnCFOBuy3,492$15.75$54,999.00  
9/9/2024Gordon DunnCFOBuy253$27.65$6,995.45  
9/4/2024Denise P CarterCOOBuy908$27.30$24,788.40  
9/3/2024Michael MyersCEOBuy22$21.70$477.40  
(Data available from 1/1/2013 forward)

QNRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Quoin Pharmaceuticals includes Anthony James Culverwell, Denise P Carter, Dennis Langer, Gordon Dunn, and Michael Myers. Learn more on insiders at QNRX.

13.46% of Quoin Pharmaceuticals stock is owned by insiders. Learn more on QNRX's insider holdings.

The following insiders have purchased QNRX shares in the last 24 months: Anthony James Culverwell ($44,997.75), Denise P Carter ($274,788.15), Gordon Dunn ($61,994.45), and Michael Myers ($477.40).

Insiders have purchased a total of 23,405 QNRX shares in the last 24 months for a total of $382,257.75 bought.

The following insider sold QNRX shares in the last 24 months: Dennis Langer ($204.40).

Insiders have sold a total of 8 Quoin Pharmaceuticals shares in the last 24 months for a total of $204.40 sold.

Quoin Pharmaceuticals Key Executives

  • Dr. Michael Myers Ph.D. (Age 62)
    Co-Founder, CEO & Chairman
    Compensation: $661.8k
  • Ms. Denise Carter (Age 55)
    Co-Founder, COO & Director
    Compensation: $537.8k
  • Mr. Gordon Bruce Dunn J.D. (Age 60)
    Chief Financial Officer
    Compensation: $394.2k


This page (NASDAQ:QNRX) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners